Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	19.51	11.29	14.69	9.6	34.89	32.67
Short-Term Investments	79.06	140.23	24.79	31.82	-	-
Cash & Short-Term Investments	98.57	151.52	39.49	41.42	34.89	32.67
Cash Growth	15.92%	283.70%	-4.67%	18.74%	6.79%	230.45%
Receivables	0.06	10.37	10.37	0.55	0.39	0.06
Prepaid Expenses	2.33	1.5	1	0.92	1.16	0.96
Total Current Assets	100.95	163.39	50.86	42.89	36.44	33.68
Property, Plant & Equipment	25	6.87	7.61	6.94	4.62	0.85
Other Intangible Assets	-	-	-	-	-	0
Other Long-Term Assets	0.49	0.22	0.27	0.27	0.28	0.09
Total Assets	126.44	170.48	58.73	50.09	41.33	34.62
Accounts Payable	2.72	8.18	6.24	4.83	3.12	2.72
Accrued Expenses	9.93	0.01	0.01	0.09	0.6	0.01
Current Portion of Long-Term Debt	-	-	-	-	-	0.25
Current Portion of Leases	0.12	0.83	0.75	0.68	0.42	-
Current Unearned Revenue	12	12	24.27	17.98	-	-
Other Current Liabilities	3.38	-	-	-	-	-
Total Current Liabilities	28.15	21.03	31.27	23.59	4.13	2.97
Long-Term Debt	-	-	-	-	-	0.07
Long-Term Leases	14.42	0.62	1.49	1.88	2.45	-
Long-Term Unearned Revenue	-	-	-	9.47	-	-
Other Long-Term Liabilities	-	3.38	3.38	3.38	3.38	3.38
Total Liabilities	42.57	25.02	36.13	38.31	9.96	6.42
Common Stock	0.05	0.05	0.03	0.03	0.02	0.02
Additional Paid-In Capital	357.68	344.22	181.7	148.74	139.4	116.22
Retained Earnings	-274.71	-199.83	-159.37	-137.08	-108.06	-88.04
Comprehensive Income & Other	0.84	1.03	0.24	0.11	-	-
Shareholders' Equity	83.87	145.46	22.6	11.79	31.37	28.2
Total Liabilities & Equity	126.44	170.48	58.73	50.09	41.33	34.62
Total Debt	14.54	1.45	2.24	2.56	2.87	0.32
Net Cash (Debt)	84.02	150.06	37.25	38.86	32.01	32.35
Net Cash Growth	0.77%	302.84%	-4.14%	21.38%	-1.03%	227.23%
Net Cash Per Share	1.85	4.26	1.39	1.58	1.39	2.08
Filing Date Shares Outstanding	45.72	45.68	31.4	25.26	24.3	22.8
Total Common Shares Outstanding	45.72	45.58	31.15	25.24	24.19	20.58
Working Capital	72.8	142.36	19.59	19.3	32.3	30.71
Book Value Per Share	1.83	3.19	0.73	0.47	1.30	1.37
Tangible Book Value	83.87	145.46	22.6	11.79	31.37	28.2
Tangible Book Value Per Share	1.83	3.19	0.73	0.47	1.30	1.37
Machinery	7.65	6.51	5.64	4.38	0.04	1.52
Leasehold Improvements	2.79	2.5	2.13	1.39	2.51	0.05

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q